Next Article in Journal
Online and Blended Learning Courses for Healthcare Professionals and Policymakers on Patients’ Perspectives on Medicine: A Project Report
Next Article in Special Issue
Online Pharmacies Selling Prescription Drugs: Systematic Review
Previous Article in Journal
Engaging Patient Advisory Boards of African American Community Members with Type 2 Diabetes in Implementing and Refining a Peer-Led Medication Adherence Intervention
Previous Article in Special Issue
Perceptions of Pharmacy Students on the E-Learning Strategies Adopted during the COVID-19 Pandemic: A Systematic Review
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Pharmacy
Volume 10
Issue 2
10.3390/pharmacy10020038
pharmacy-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Evaluation of Current Community Pharmacist Practice in Saudi Arabia—A Cross-Sectional Study from Pharmacists’ Perspective (Part II)

by
Mohammad Alhazmi
1,
Abdulmajeed Bajuayfir
2,
Ejaz Cheema
3,
Mahmoud Elrggal
4 and
Majid Ali
5,*
1
Pharmacy Services, Ministry of Health, Al-Baha 11176, Saudi Arabia
2
Retail Department, Al-Dawaa Pharmacies, Al-Khobar 34621, Saudi Arabia
3
School of Pharmacy, University of Management and Technology, Lahore 54770, Pakistan
4
Faculty of Pharmacy, Umm Al-Qura University, Makkah 24382, Saudi Arabia
5
School of Life and Medical Sciences, University of Hertfordshire (Hosted by Global Academic Foundation), New Administrative Capital, Cairo 11835, Egypt
*
Author to whom correspondence should be addressed.
Pharmacy 2022, 10(2), 38; https://0-doi-org.brum.beds.ac.uk/10.3390/pharmacy10020038
Submission received: 19 January 2022 / Revised: 28 February 2022 / Accepted: 1 March 2022 / Published: 10 March 2022
(This article belongs to the Special Issue The 10th Anniversary of Pharmacy—Advances in Pharmacy Education and Practice)
Versions Notes

Abstract

:
This study aimed to evaluate the current practice of community pharmacists from patients’ and pharmacists’ perspectives in Saudi Arabia. This paper presents the pharmacist’s perspective. A cross-sectional self-administered online survey was designed to collect responses from community pharmacists in Saudi Arabia from February to April 2021. The questionnaire consisted of several statements related to best practice in community pharmacy. Pharmacists’ responses to each statement were scored using a 5-point Likert scale. Higher scores represented a greater extent to which they adhered to best practice in the community pharmacy setting and vice versa. Data of 164 participants were included in the analysis. The minimum median score was related to the statement: Pharmacist explains the main side effects. The maximum median score was related to the statement: Pharmacist explains dosage regimen. Pharmacists aged 30 years or above and non-Saudi pharmacists had significantly higher median scores compared with pharmacists less than 30 years of age (p = 0.016) and Saudi pharmacists, respectively (p = 0.001). A gap between best practice and current practice of community pharmacists was observed. Policymakers can utilize these findings to provide targeted professional development opportunities for the practicing community pharmacists in order to improve the overall service and care for patients.

1. Introduction

Professional pharmacy services are defined as “an action or set of actions undertaken in or organized by a pharmacy, delivered by a pharmacist or other health practitioner, who applies their specialized health knowledge personally or via an intermediary, with a patient/client, population or other healthcare professionals, to optimize the process of care, with the aim to improve health outcomes, and the value of healthcare” [1]. Community pharmacies are considered the first in line for patients regarding ease of access to obtain their medication and health services. Pharmacists in community pharmacies can provide medical services for numerous patients in a day with or without appointments. These services can be seeking advice, reassurance, treatment, or even a combination of all these [2].
The core functions of the community pharmacist range from recommending suitable non-prescription products to detecting and minimizing any side effects that may harm patients related to the prescription medicines, among which patient counseling is an integral part [3]. Thus, there are many factors that contribute to the satisfaction of the patient. A significant increase in the number of patients worldwide who visit community pharmacies as compared to health care centers can be attributed to several reasons, including the low cost of services offered by the pharmacies, less waiting time, and more time spent with the pharmacist. Saudi Arabia is no different. Ample evidence suggests that people in Saudi Arabia frequently visit their community pharmacies for various reasons [4,5,6,7,8]. Hence, there is an increased public demand for utilizing community pharmacy services. There is also an opportunity for community pharmacies to contribute to the country’s Vision 2030, which promises public–private partnerships for effective primary health care [9,10]. Because of these reasons, it is imperative to provide good-quality and standardized community pharmacy services. This study aimed to evaluate the current practice of community pharmacists from patients’ and pharmacists’ perspectives in Saudi Arabia in order to identify the potential areas for improvement that can ultimately be used to develop recommendations for policymakers. This paper presents the methods, results, discussion, and conclusions related to the pharmacist’s perspective. The patient perspective is presented in Part I of our study.

2. Methods

2.1. Study Design

A cross-sectional self-administered online survey was employed in this study to collect the pharmacists’ responses.

2.2. Instrument

We developed the survey instrument (questionnaire) based on the relevant literature and personal observations and practices [11,12,13,14,15]. The questionnaire consisted of three parts. Part I comprised the demographic characteristics of the pharmacists, such as gender, age, the geographical location where they were practicing, nationality, and educational background. Part II consisted of questions related to their working experience in Saudi Arabia and knowledge of any regulations regarding pharmacist and community pharmacist practice in Saudi Arabia. Part III comprised statements related to best practice in community pharmacy. A 5-point Likert scale was used for each statement to record pharmacists’ responses. Pharmacists’ responses to each statement were scored to assess the extent to which they perform best practice in community pharmacies (Never = 1, Rarely = 2, Sometimes = 3, Often = 4, Always = 5). Higher scores represented a greater extent to which they adhere to best practice in the community pharmacy setting and vice versa.
In order to detect pharmacists who randomly selected options on the Likert scale, we included the following statement in the questionnaire with Likert scale options: Ask for extra money from the patient. As opposed to the other statements, the ‘always’ option for this statement would illustrate worst practice by the pharmacist. It was decided to delete all the data from the analysis for these pharmacists, who may have selected ‘always’ for all the statements (including this one), assuming that this would indicate random responses to the statements by the pharmacist.
The questionnaire was developed and administered in the English language. The questionnaire was piloted with three pharmacists, and minor changes were made in the wording of some questions.

2.3. Validity and Reliability of the Instrument

We ensured the face validity of the questionnaire with the help of two experienced community pharmacists and two expert academic researchers to establish the relevance and reasonability of the questions without any ambiguity. They also checked the questionnaire’s content to ensure that the instrument was logical and easy to understand (content validity). The reliability analysis of Part III of the instrument showed a Cronbach’s alpha value of 0.91, indicating strong internal consistency.

2.4. Participants and Setting

All pharmacists working in the community pharmacy setting in Saudi Arabia were eligible to participate in the survey. The survey was disseminated via an online link using Google Forms on various social media accounts and relevant WhatsApp groups for pharmacists, and no incentives or compensation was offered for completing the survey. The data were collected from February 2021 to April 2021.

2.5. Statistical Analysis

The data were downloaded from Google Forms as an Excel file and then exported to SPSS (Version 24) for descriptive and inferential statistical analyses. Only the researchers had access to the files. The descriptive analysis demonstrated patients’ demographic characteristics and responses in frequencies, percentages, and medians with standard deviations. Furthermore, the Mann–Whitney U t-test and Kruskal–Wallis test were utilized to determine the effect of the independent variables (gender, age, geographical location, nationality, and marital status) on the dependent variables (median score of all the statements), and a p-value of less than 0.05 was considered statistically significant.
Currently, there are an estimated 24,395 community pharmacists dispensing pharmaceutical products in community pharmacies across the country [16]. The sample size determined by an online sample size calculator (SurveyMonkey, San Mateo, CA, USA) with a 95% confidence interval and a 5% margin error was 379 community pharmacists.

2.6. Ethical Considerations

This study was reviewed and approved by the Institutional Review Board (IRB) of Umm Al-Qura University (approval number: HAPO-02-K-012-2021-04-655). The survey introduction informed the pharmacists about their voluntary participation in the survey, the anonymity and confidentiality of the collected data, and their right to withdraw their information at any time by contacting the researchers.

3. Results

3.1. Demographics

A total of 169 pharmacists responded to the survey. The data of five participants were deleted because they were deemed random responses (explanation in the methods section). The data of 164 participants were included in the analysis. More than half of them were males (n = 116; 71%). The majority of the participants were Saudi nationals (n = 122; 75%) and less than 30 years old (n = 123; 75%). The northern region of Saudi Arabia was the geographical location where the highest percentage of participants responded from (n = 64; 39%). Table 1 shows more details regarding the demographic characteristics of the participants.

3.2. Responses to the Statements

Participants’ responses to the statements are illustrated in Table 2. The median score of the individual statements ranged from 3.26 (2.00) to 4.34 (1.01) (5 being the maximum possible score for each statement). The minimum median score was related to the statement: Pharmacist explains the main side effects. The maximum median score was related to the statement: Pharmacist explains dosage regimen (dose and frequency). The overall median score of all the statements was 77 (14), ranging from 30 to 100 (maximum possible score of 100).
The Mann–Whitney U t-test revealed no significant difference in the median scores between male and female pharmacists: 3.86 (0.67) versus 3.81 (0.75); p = 0.958. However, pharmacists aged 30 years or above and non-Saudi pharmacists had significantly higher median scores compared with pharmacists less than 30 years of age (p = 0.016) and Saudi pharmacists (p = 0.001), respectively. Moreover, those who were aware of any regulation about pharmacists’ role in Saudi Arabia and aware of any regulation about community pharmacists’ role in Saudi Arabia also had significantly higher median scores compared with those who were not aware.
The Kruskal–Wallis test revealed a statistically significant difference in the median scores of the participants from different regions (p = 0.008). Participants from the northern region had the highest median score, 4.03 (0.64), whereas participants from the central region had the lowest median score, 3.44 (0.78). No significant difference was observed in the median scores of the pharmacists with different educational backgrounds and different working experiences in Saudi Arabia.

4. Discussion

Our study was an exploratory study in which we evaluated the current practice of community pharmacists from their own perspective in Saudi Arabia. In previous studies, community pharmacists have successfully been able to self-evaluate their practices and competencies [17,18]. Standards for the quality of pharmacy services have been set by the World Health Organization [11]. Studies from other countries have shown varying results related to the evaluation of community pharmacy services [13,14,15]. In our study, a scale based on best community pharmacist practices was developed utilizing the literature, and community pharmacists were asked to rate their practice on this scale, following which we quantified their responses [11,12,13,14,15].
We found that the median score of male and female pharmacists was above 3.8, and there was no significant difference found between them, meaning they evaluated themselves to be performing best practice equally well. However, the number of male pharmacists in our study sample was more than double that of female pharmacists. This reflects the effect of culture on the workforce in Saudi Arabia, in which females are still reluctant to accept retail jobs. However, because of the recent reforms taking place in the country, a shift in the workforce is anticipated [19,20,21]. Alhaddad and colleagues evaluated the satisfaction of female patients with the services received from male community pharmacists in Saudi Arabia and reported that less than half of patients were satisfied with the services they received from male pharmacists; more than half were embarrassed to discuss sensitive female issues with the male pharmacists and preferred the presence of female pharmacists in community pharmacies [22]. With the anticipated shift in the workforce in the country, we expect to have more female pharmacists available in community pharmacies to serve female patients.
We also found that we had a higher number of young and newly graduated Saudi pharmacists in our study sample. This again reflects the workforce reforms taking place in Saudi Arabia, which is creating a significantly increased number of job opportunities for young people in every sector compared with past numbers. With more young pharmacists joining the workforce, we can expect an improvement in the quality of pharmaceutical care provided in community pharmacies; one study reported that younger pharmacists are generally more supportive of pharmaceutical care and exhibit best practice of pharmaceutical care [23]. Another promising finding was that majority of the pharmacists were aware of the pharmacy regulations in the country. However, it was alarming to observe that approximately 20% of the pharmacists were not aware of any pharmacy regulations. This raises serious concerns regarding the qualification and licensing of these pharmacists to practice in community pharmacies.
Our study also revealed a significant difference in the median scores of community pharmacists from different regions of the country. The community pharmacists in the northern region had the highest score, whereas those in the central region had the lowest score, and this difference was significant. This coincides with the patient evaluation of community pharmacist practices reported in Part I of our study, in which patients in the northern region also scored significantly higher compared with patients in the central region. It must be noted that the population demographics of Saudi Arabia vary from region to region [24]. Some areas are more populated with non-Saudis, and others are more populated with the people of middle age and the elderly. Moreover, the central region is the most populous, and community pharmacists may not have sufficient time to provide good-quality pharmacy services to patients in busy community pharmacies [25]. Furthermore, in community pharmacies, patients prefer a private area for discussing personal health issues [26], and this may not be possible in crowded community pharmacies. By contrast, the northern region is less populous than the central region, and pharmacists may have ample time to build good relationships and rapport with their patients in community pharmacies. This may explain the reasons for the differences in patient expectations and community pharmacist practices in these regions.
The statement on which the pharmacists scored the lowest compared with the other statements was: “Explain main side effects (to the patients)”. This coincides with findings of the patient evaluation of community pharmacist practices reported in Part I of our study, in which this was the statement that was scored lowest by the patients. It also resonates with other studies in which community pharmacists in Saudi Arabia have been reported to be reluctant to explain medication side effects to their patients [4,25]. This may be because business still plays a crucial role in the community pharmacy practice, and the pharmacists may not be willing to explain medication side effects to patients lest this turns them away from community pharmacies.
Other statements on which both community pharmacists and patients (according to findings on the patient perspective reported in Part I of our study) scored low were: “Discuss complementary medications the patient may be taking”, “Discuss general health issues of the patient”, and “Follow up with the patients about their health”. Al-Arifi also reported that community pharmacists in Saudi Arabia did not provide adequate counseling to patients regarding complementary medications [27]. Likewise, Khdour and Hallaki reported that pharmacists generally do not discuss general health issues with patients in community pharmacies [28].
The four statements that achieved a median score of more than 4 (out of total 5) were: “Explain dosage regimen (dose and frequency) to the patient”, “Explain dosage regimen (administration) to the patient”, “Ensure understanding of dosage regimen by the patient”, and “Use simple (non-medical) terms when talking to the patient or customer”. Interestingly, the first two statements and the last statement coincided with the statements that were also scored higher than 4 by the patients when evaluating the community pharmacy practice (reported in Part I of our study). A study from the United Arab Emirates reported that community pharmacists explain to patients how to use their medication on 98% of occasions [29]. By contrast, in a study from Iraq, community pharmacists were not generally found to check the prescriptions for dose and frequency accuracy [30].

Limitations

The findings of our study must be interpreted considering the limitations. It was only an exploratory study, and we were not able to achieve the required sample size because of time constraints. Moreover, we utilized a self-completed online questionnaire that could be subject to the misunderstanding of the questions and memory bias.

5. Conclusions

Despite the limited sample size, our results provide insight into the status of current practice by community pharmacists in Saudi Arabia from their own perspective. Our study highlights a gap between current practice and best practice of community pharmacists as evaluated by the pharmacists. The pharmacists should consider including a clear and elaborate explanation of the main medication side effects; counseling on complementary medications the patient might be taking or be interested in taking; and discussing general health issues related to their interactions with the patients in community pharmacies. They should also follow up with the patients about their medications and health whenever possible. Policymakers can utilize these findings to provide targeted professional development opportunities for practicing community pharmacists in order to improve the overall service and care for patients.

Author Contributions

M.A. (Majid Ali), E.C. and M.E. conceived the project and wrote the proposal; A.B. and M.A. (Mohammad Alhazmi) designed the data collection forms, collected and analyzed the data, and prepared the first draft of the manuscript; M.A. (Majid Ali), E.C. and M.E. revised the manuscript. All authors have read and agreed to the published version of the manuscript.

Funding

This research received no external funding.

Institutional Review Board Statement

The study was conducted according to the guidelines of the Declaration of Helsinki and approved by the Institutional Review Board (IRB) of Umm Al-Qura University (approval number: HAPO-02-K-012-2021-04-655).

Informed Consent Statement

Subjects’ participation in the survey was voluntary and was considered their consent to take part in the study.

Data Availability Statement

The data presented in this study are available upon request from the corresponding author.

Acknowledgments

The authors would like to thank all the participants of this survey and the academic staff who helped facilitate this study.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Donabedian, A. Evaluating the Quality of Medical Care. Milbank Q. 2005, 83, 691–729. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Hasan, S.; Sulieman, H.; Chapman, C.; Stewart, K.; Kong, D. Community pharmacy services in the United Arab Emirates. Int. J. Pharm. Pract. 2012, 20, 218–225. [Google Scholar] [CrossRef] [PubMed]
  3. Wirth, F.; Tabone, F.; Azzopardi, L.; Gauci, M.; Zarb-Adami, M.; Serracino-Inglott, A. Consumer perception of the community pharmacist and community pharmacy services in Malta. J. Pharm Health Serv. Res. 2010, 1, 189–194. [Google Scholar] [CrossRef]
  4. Rasheed, M.; Alqasoumi, A.; Hasan, S.; Babar, Z. The community pharmacy practice change towards patient-centered care in Saudi Arabia: A qualitative perspective. J. Pharm. Policy Pract. 2020, 13, 59. [Google Scholar] [CrossRef] [PubMed]
  5. Al-jedai, A.; Qaisi, S.; Al-meman, A. Pharmacy Practice and the Health Care System in Saudi Arabia. Can. J. Hosp. Pharm. 2016, 69, 231–237. [Google Scholar] [CrossRef] [PubMed]
  6. Al-Arifi, M. Patients’ perception, views and satisfaction with pharmacists’ role as health care provider in community pharmacy setting at Riyadh, Saudi Arabia. Saudi Pharm. J. 2012, 20, 323–330. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  7. Al-Tannir, M.; Alharbi, A.; Alfawaz, A.; Zahran, R.; AlTannir, M. Saudi adults satisfaction with community pharmacy services. Springerplus 2016, 5, 774. [Google Scholar] [CrossRef] [Green Version]
  8. Bawazir, S. Consumer attitudes towards community pharmacy services in Saudi Arabia. Int. J. Pharm. Pract. 2004, 12, 83–89. [Google Scholar] [CrossRef]
  9. The Government of Saudi Arabia. The Kingdom of Saudi Arabia Vision 2030. Vision Realization Programs. 2019. Available online: https://www.vision2030.gov.sa/v2030/vrps/ (accessed on 5 September 2021).
  10. Ministry of Health, KSA. Key Health Indicators. 2020. Available online: https://www.moh.gov.sa/en/Ministry/Statistics/Indicator/Pages/default.aspx (accessed on 5 September 2021).
  11. World Health Organization (WHO). Joint FIP/WHO Guidelines on Good Pharmacy Practice: Standards for Quality of Pharmacy Services. 2011. Available online: https://www.who.int/medicines/areas/quality_safety/quality_assurance/FIPWHOGuidelinesGoodPharmacyPracticeTRS961Annex8.pdf (accessed on 11 February 2022).
  12. Eades, C.; Ferguson, J.; O’Carroll, R. Public health in community pharmacy: A systematic review of pharmacist and consumer views. BMC Public Health 2011, 11, 582. [Google Scholar] [CrossRef] [Green Version]
  13. Hindi, A.; Schafheutle, E.; Jacobs, S. Patient and public perspectives of community pharmacies in the United Kingdom: A systematic review. Health Expect. 2017, 21, 409–428. [Google Scholar] [CrossRef]
  14. Melton, B.; Lai, Z. Review of community pharmacy services: What is being performed, and where are the opportunities for improvement? Integr. Pharm. Res. Pract. 2017, 6, 79–89. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  15. Patel, P.; Vaidya, V.; Osundina, F.; Comoe, D. Determining patient preferences of community pharmacy attributes: A systematic review. J. Am. Pharm. Assoc. 2020, 60, 397–404. [Google Scholar] [CrossRef] [PubMed]
  16. Alshahrani, A. Readiness of community pharmacists to play a supportive and advocacy role in the fight against coronavirus disease. Risk Manag. Healthc. Policy 2020, 13, 3121–3133. [Google Scholar] [CrossRef] [PubMed]
  17. Mills, E.; Laaksonen, R.; Bates, I.; Davies, G.; Duggan, C. Self-assessment of competence in a community pharmacy setting. Pharm. Educ. 2005, 5, 189–199. [Google Scholar] [CrossRef]
  18. Držaić, M.; Kummer, I.; Mucalo, I.; Bruno, A.; Ortner Hadžiabdić, M. Identifying self-assessed competencies and areas for improvement within community pharmacist-preceptors support during pre-registration training. BMC Med. Educ. 2018, 18, 303. [Google Scholar] [CrossRef]
  19. The Government of Saudi Arabia. The Kingdom of Saudi Arabia Vision 2030. Progress and Achievements. 2019. Available online: https://www.vision2030.gov.sa/v2030/achievements/ (accessed on 5 September 2021).
  20. Almaghaslah, D.; Alsayari, A.; Asiri, R.; Albugami, N. Pharmacy workforce in Saudi Arabia: Challenges and opportunities: A cross-sectional study. Int. J. Health Plan. Manag. 2018, 34, e583–e593. [Google Scholar] [CrossRef] [Green Version]
  21. Shadmand, S.L.; Biesenthal, B.K.; Beaumont, J.S.; Gidalevitz, O. Saudi Arabia Introduces Significant Labor Reforms. Society for Human Resource Management (SHRM). 2020. Available online: https://www.shrm.org/resourcesandtools/hr-topics/global-hr/pages/saudi-arabia-labor-reform-initiative.aspx (accessed on 8 October 2021).
  22. Alhaddad, M.; Mudhish, E.; Bukhari, R.; Aladwani, A.; Asiri, S. Assessment of Female Satisfaction with the Role of Male Community Pharmacists in the Kingdom of Saudi Arabia. J. Clin. Diagn. Res. 2018, 12, 1–5. [Google Scholar] [CrossRef]
  23. Dunlop, J.; Shaw, J. Community pharmacists′ perspectives on pharmaceutical care implementation in New Zealand. Pharm. World Sci. 2002, 24, 224–230. [Google Scholar] [CrossRef]
  24. General Authority for Statistics, KSA. Population in Saudi Arabia by Gender, Age, Nationality (Saudi/Non-Saudi)–Mid 2016 A.D. 2016. Available online: https://www.stats.gov.sa/en/5305 (accessed on 8 October 2021).
  25. Al Qarni, H.; Alrahbini, T.; AlQarni, A.; Alqarni, A. Community pharmacist counselling practices in the Bisha health directorate, Saudi Arabia–Simulated patient visits. BMC Health Serv. Res. 2020, 20, 745. [Google Scholar] [CrossRef]
  26. Hattingh, H.; Emmerton, L.; Ng Cheong Tin, P.; Green, C. Utilization of community pharmacy space to enhance privacy: A qualitative study. Health Expect. 2015, 19, 1098–1110. [Google Scholar] [CrossRef] [Green Version]
  27. Al-Arifi, M. Availability and needs of herbal medicinal information resources at community pharmacy, Riyadh region, Saudi Arabia. Saudi Pharm. J. 2013, 21, 351–360. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  28. Khdour, M.; Hallak, H. Societal perspectives on community pharmacy services in West Bank-Palestine. Pharm. Pract. 2012, 10, 17–24. [Google Scholar] [CrossRef] [PubMed]
  29. Hasan, S.; Sulieman, H.; Stewart, K.; Chapman, C.; Kong, D. Patient expectations and willingness to use primary care pharmacy services in the United Arab Emirates. Int. J. Pharm. Pract. 2015, 23, 340–348. [Google Scholar] [CrossRef] [PubMed]
  30. Ibrahim, I.; Al Tukmagi, H.; Wayyes, A. Attitudes of Iraqi society towards the role of community pharmacists. Innov. Pharm. 2013, 4, 114. [Google Scholar] [CrossRef] [Green Version]
Table
Table 1. Demographic characteristics of the participants (n = 164) with the comparison of their median scores.
Table 1. Demographic characteristics of the participants (n = 164) with the comparison of their median scores.
Demographic CharacteristicsNumber of ParticipantsMedian Score (IQR)p-Value
Gender 0.958
Male1163.86 (0.67)
Female483.81 (0.75)
Age 0.017
Less than 30 years1233.77 (0.68)
30 years or above414.06 (0.69)
Geographical location 0.008
Central region223.44 (0.78)
Eastern region 143.68 (0.58)
Northern region644.03 (0.64)
Southern region283.79 (0.73)
Western region363.87 (0.65)
Nationality 0.003
Saudi1223.75 (0.70)
Non-Saudi424.12 (0.58)
Educational background 0.431
BPharm853.92 (0.63)
PharmD703.76 (0.70)
Postgraduate degree93.75 (1.14)
Working experience as a pharmacist in KSA 0.265
1 year833.80 (0.59)
2 years253.81 (0.92)
3 or more years563.93 (0.73)
Aware of any regulation about pharmacist role in Saudi Arabia <0.001
Yes1303.93 (0.68)
No343.50 (0.64)
Aware of any regulation about community pharmacist role in Saudi Arabia 0.018
Yes1103.94 (0.67)
No543.66 (0.70)
IQR: interquartile range.
Table
Table 2. Participants’ frequencies (with percentages) and the median scores (with standard deviation) for the statements.
Table 2. Participants’ frequencies (with percentages) and the median scores (with standard deviation) for the statements.
StatementNever (%)Rarely (%)Sometimes (%)Often (%)Always (%)Median (IQR)
1. Ask about current medications of the patient11 (6.7)10 (6.1)38 (23.2)40 (24.4)65 (39.6)3.84 (1.21)
2. Ask about comorbid diseases the patient may have8 (4.9)12 (7.3)36 (22)52 (31.7)56 (34.1)3.83 (1.13)
3. Explain dosage regimen (dose and frequency) to the patient8 (4.9)5 (3)17 (10.4)28 (17.1)106 (64.6)4.34 (1.10)
4. Explain dosage regimen (administration) to the patient10 (6.1)3 (1.8)16 (9.8)30 (18.3)105 (64)4.32 (1.12)
5. Ensure understanding of dosage regimen by the patient8 (4.9)6 (3.7)20 (12.2)33 (20.1)97 (59.1)4.25 (1.12)
6. Explain main side effects12 (7.3)31 (18.9)57 (34.8)30 (18.3)34 (20.7)3.26 (1.20)
7. Ask for extra money from the patient *132 (80.5)7 (4.3)10 (6.1)5 (3.0)10 (6.1)1.5 (1.1)
8. Discuss complementary medications the patient may be taking8 (4.9)18 (11)58 (35.4)33 (20.1)47 (28.7)3.57 (1.16)
9. Discuss general health issues of the patient 5 (3)16 (9.8)57 (34.8)37 (22.6)49 (29.9)3.66 (1.10)
10. Discuss the patient’s concerns about medications6 (3.7)14 (8.5)55 (33.5)42 (25.6)47 (28.7)3.67 (1.09)
11. Use simple (non-medical) terms when talking to the patient or customer0 (0)8 (4.9)38 (23.2)30 (18.3)88 (53.7)4.21 (0.96)
12. Ensure patient compliance with the medications8 (4.9)10 (6.1)49 (29.9)31 (18.9)66 (40.2)3.84 (1.17)
13. Provide the patient written information about medications whenever needed6 (3.7)14 (8.5)31 (18.9)38 (23.2)75 (45.7)3.99 (1.15)
14. Handle consultations on sensitive topics appropriately8 (4.9)13 (7.9)44 (26.8)37 (22.6)62 (37.8)3.8 (1.17)
15. Provide clear non-verbal instructions on patient counseling for patients/customers who cannot hear 11 (6.7)13 (7.9)37 (22.6)40 (24.4)63 (38.4)3.8 (1.22)
16. Follow up with the patients about their health12 (7.3)28 (17.1)50 (30.5)32 (19.5)42 (25.6)3.39 (1.24)
17. Solve medication-related problems whenever needed4 (2.4)21 (12.8)49 (29.9)39 (23.8)51 (31.1)3.68 (1.12)
18. Promote health awareness4 (2.4)11 (6.7)41 (25)37 (22.6)71 (43.3)3.98 (1.09)
19. Provide patient care relevant to the Saudi culture 11 (6.7)8 (4.9)43 (26.2)36 (22)66 (40.2)3.84 (1.20)
20. Follow the mechanisms for checking dispensing procedures in the pharmacy10 (6.1)18 (11)30 (18.3)40 (24.4)66 (40.2)3.82 (1.25)
21. Ensure proper labeling of the medications before dispensing5 (3)16 (9.8)36 (22)40 (24.4)67 (40.9)3.9 (1.14)
IQR: interquartile range. * Not included in the analysis.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Alhazmi, M.; Bajuayfir, A.; Cheema, E.; Elrggal, M.; Ali, M. Evaluation of Current Community Pharmacist Practice in Saudi Arabia—A Cross-Sectional Study from Pharmacists’ Perspective (Part II). Pharmacy 2022, 10, 38. https://0-doi-org.brum.beds.ac.uk/10.3390/pharmacy10020038

AMA Style

Alhazmi M, Bajuayfir A, Cheema E, Elrggal M, Ali M. Evaluation of Current Community Pharmacist Practice in Saudi Arabia—A Cross-Sectional Study from Pharmacists’ Perspective (Part II). Pharmacy. 2022; 10(2):38. https://0-doi-org.brum.beds.ac.uk/10.3390/pharmacy10020038

Chicago/Turabian Style

Alhazmi, Mohammad, Abdulmajeed Bajuayfir, Ejaz Cheema, Mahmoud Elrggal, and Majid Ali. 2022. "Evaluation of Current Community Pharmacist Practice in Saudi Arabia—A Cross-Sectional Study from Pharmacists’ Perspective (Part II)" Pharmacy 10, no. 2: 38. https://0-doi-org.brum.beds.ac.uk/10.3390/pharmacy10020038

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop